News & Updates
Filter by Specialty:
Young-onset diabetes: Novel insights on management
At EmW 2025, Professor Andrea Luk from the Department of Medicine & Therapeutics, the Chinese University of Hong Kong, shared insights and recommendations on management of young-onset diabetes (YoD).
Young-onset diabetes: Novel insights on management
28 Oct 2025
HK data: LAI antipsychotics superior to oral antipsychotics in older patients with schizophrenia
Long-acting injectable (LAI) antipsychotics are associated with lower risks of disease relapse and mortality than oral antipsychotics in older patients with schizophrenia, a population-based study in Hong Kong has shown.
HK data: LAI antipsychotics superior to oral antipsychotics in older patients with schizophrenia
28 Oct 2025
Soft drinks may fuel depression via gut microbiome
Consumption of soft drinks predicts major depressive disorder (MDD) diagnosis and symptom severity in women through gut microbiota alterations, a cohort study has shown.
Soft drinks may fuel depression via gut microbiome
28 Oct 2025
Enzalutamide-ADT a win for biochemically recurrent prostate cancer
In the final overall survival (OS) analysis of the phase III EMBARK trial, the combination of enzalutamide and androgen deprivation therapy (ADT; leuprolide acetate) delivers a significant OS benefit in men with high-risk biochemically recurrent (hrBCR) prostate cancer without evidence of metastases on conventional imaging.
